DRP3

Welcome to the Brand page for “DRP3”, which is offered here for Educational services, providing educational programs in the nature of classes, seminars, and workshops about neurodegenerative diseases and disorders and dementia and diagnosis, identification, management, treatment, and patient support options for these conditions; multimedia educational services in the nature of recording and production services in the fields of neurodegenerative diseases and disorders and dementia, medical informational support services, and medical information regarding disease diagnosis, identification, treatment, and management distributed via various platforms across multiple forms of transmission media; providing on-line newsletters in the field of neurodegenerative diseases and disorders and dementia, medical informational support services, and medical information regarding disease diagnosis, identification, treatment, and management; online non-downloadable electronic publications in the nature of brochures, pamphlets, newsletters, articles and guidebooks in the field of neurodegenerative diseases and disorders and dementia, patient support, and medical information regarding disease diagnosis, identification, management, and treatment;the mark consists of the stylized wording drp3 within a rectangle as a carrier.;downloadable electronic publications in the nature of brochures, pamphlets, newsletters, articles and guidebooks in the field of neurodegenerative diseases and disorders and dementia, patient support, and medical information regarding disease diagnosis, identification, management, and treatment;printed publications in the nature of brochures, pamphlets, newsletters, articles and guidebooks in the field of neurodegenerative diseases and disorders and dementia, patient support, and medical information regarding disease diagnosis, identification, management, and treatment; printed questionnaires on medical issues;dementia-related psychosis three;drp three;promoting awareness of patient support offerings for neurodegenerative diseases and disorders and dementia; business administrative services for medical referrals;medical consulting with respect to neurodegenerative diseases and disorders and dementia, including dementia-related psychosis and their identification and treatment; providing medical online information for health care providers and patients in the field of neurodegenerative diseases and disorders and dementia; medical informational support services, providing medical information about the benefits of diagnostic tools, medical information regarding disease diagnosis, identification, treatment, and management, and healthcare-related information to patients and healthcare professionals all related to neurodegenerative diseases and disorders and dementia;testing, inspection, research, and development of diagnostic tests and questionnaires for symptoms of dementia-related psychosis, including hallucinations and delusions associated with dementia-related psychosis;.

Its status is currently believed to be active. Its class is unavailable. “DRP3” is believed to be currently owned by “ACADIA Pharmaceuticals, Inc.”